Pfizer CEO Mentioned No Drug Price Commitments by Pfizer Inc. (PFE)

Pfizer Inc. (NYSE:PFEHe is one of The best widespread trench stocks for purchase now. On June 9 / However, Pfizer CEO, Albert Burla, stated that no obligations were agreed.

President Trump ordered the drug makers last month to cut the prices of their drugs so that they would coincide with what other countries pay. According to this executive matter, the government had to choose the “most preferred nation” target prices in 30 days. The Ministry of Health and Humanitarian Services has called for drug makers in the United States to review their prices to comply with the lowest price paid by high -income countries.

At the Goldman Sachs Global Healthcare conference, Albert Burla commented:

“I don’t know what we will hear in 30 days,”

Burla added: Pfizer concentration is repeated on high -level ideas:

“The administration has already started a series of meetings with companies … … the meetings were friendly, but they were not digging in the article,”

A medical technician wears protective gloves and a mask that mixes the vital pharmaceutical solution.

Currently, it is not clear how the United States government will reduce drug prices, and it will be difficult to implement this policy, according to analysts and legal professionals. A spokesman commented that the Minister of Health Robert F. Kennedy Junior will launch a system as American patients can buy their medicine directly from drug makers who sell to Americans at the “most preferred” price.

Porla of Pfizer hoped that the total number of drugs would rise due to the American pressure on European countries. He stated that if America begins to control prices, then Pfizer Inc. (NYSE: PFE) can block medicines to pay the government in some countries if the prices do not increase there. Clear:

“I don’t think we will remove our products from the market there – we will just remove them from payment. We will leave them in the open market.”

Pfizer manufactures and sells biological pharmaceutical products around the world, meets heart health needs, infectious diseases, migraines, immune disorders, and cancer.

Although we acknowledge the possibility of PFE as an investment, we believe that some of the artificial intelligence shares provide greater potential in the upward direction and carry less risks on the negative side. If you are looking for a stock of artificial intelligence with less than very apprecia The best inventory of artificial intelligence in the short term.

Read the following: The best and worst Dow stocks for the next 12 months and 10 shares that cannot be stopped can double your money.

Detection: Nothing.